According to BIS Research, the global transgenic animal model market is projected to reach $6,799.3 million by 2035, growing at a compound annual growth rate (CAGR) of 9.29% during the forecast period 2025–2035. The market is witnessing strong momentum driven by the increasing adoption of genetically engineered animal models in drug discovery, oncology research, immunology studies, and rare disease modeling.
Transgenic animal models organisms whose genomes have been deliberately modified using genetic engineering techniques have become foundational tools in modern biomedical research. With the rise of gene-editing platforms such as CRISPR/Cas9, TALENs, and zinc-finger nucleases, researchers can now create highly precise disease models that closely mimic human pathophysiology, significantly improving preclinical study accuracy and translational outcomes.
What Are Transgenic Animal Models and Why Are They Important in Biomedical Research?
Transgenic animal models are genetically engineered organisms whose genomes have been modified to replicate specific human disease characteristics. These models are essential tools in:
-
Drug discovery and development
-
Oncology research
-
Immunology studies
-
Rare genetic disease modeling
-
Neuroscience and cardiovascular research
With the rise of gene-editing platforms such as CRISPR/Cas9, TALENs, and zinc-finger nucleases, researchers can now create highly precise disease models that significantly improve translational accuracy and preclinical validation outcomes.
Market Overview
The projected market value of $6.8 billion by 2035 reflects sustained investment in life sciences research, growing clinical trial pipelines, and rising focus on personalized medicine.
Key Growth Indicators:
-
Market Size by 2035: $6,799.3 million
-
Forecast Period: 2025–2035
-
CAGR (2025–2035): 9.29%
Request A Sample for Transgenic Animal Model Market – Focus on Application, Product, and Regional Analysis and Forecast, 2025-2035
What Is Driving Growth in the Transgenic Animal Model Market?
Several structural factors are accelerating market growth:
1. How Is Precision Medicine Increasing Demand for Transgenic Models?
Precision medicine requires disease models that replicate specific genetic mutations and biological pathways. Transgenic models enable targeted therapy testing and biomarker validation, particularly in oncology and rare diseases.
2. How Are CRISPR and Gene-Editing Technologies Transforming Model Development?
CRISPR/Cas9 has revolutionized genetic engineering by offering faster, more cost-effective, and highly accurate genome modification. This technology has significantly reduced model development timelines and expanded access to advanced research institutions and biotech companies.
3. How Is the Growth of Biologics and Cell & Gene Therapies Impacting the Market?
The expansion of biologics, CAR-T therapies, monoclonal antibodies, and gene therapies has increased the need for advanced preclinical models. Transgenic animals are critical for assessing therapeutic efficacy, toxicity, immunogenicity, and long-term safety before clinical trials.
4. How Does Increased Research Funding Support Market Expansion?
Rising global R&D investments and public-private collaborations are expanding research capabilities. Pharmaceutical companies, academic institutions, and contract research organizations (CROs) are increasing partnerships to develop specialized transgenic models.
Market Segmentation Insights
The transgenic animal model market can be segmented based on animal type, technology, application, and end user.
Which Animal Types Dominate the Transgenic Animal Model Market?
Rodents, particularly mice and rats, dominate the market due to:
-
High genetic similarity to humans
-
Short reproductive cycles
-
Established genomic data
Large animal models such as pigs and non-human primates are gaining traction in specialized applications, including cardiovascular research, xenotransplantation, and neurological disorder studies.
Which Gene-Editing Technologies Are Leading Market Adoption?
Key technologies include:
-
CRISPR/Cas9
-
TALEN
-
Zinc-Finger Nucleases
-
Microinjection
-
Embryonic Stem Cell-Mediated Gene Transfer
CRISPR-based approaches are expected to lead due to their precision, scalability, and lower cost compared to traditional gene-targeting techniques.
What Are the Primary Applications of Transgenic Animal Models?
Major application areas include:
-
Oncology research
-
Immunology
-
Neurodegenerative disorders
-
Cardiovascular diseases
-
Rare genetic diseases
-
Metabolic disorders
-
Drug discovery and development
Oncology represents a significant revenue segment, driven by the need to replicate complex tumor microenvironments and immuno-oncology pathways.
Who Are the Key End Users in the Transgenic Animal Model Market?
The primary end users include:
-
Pharmaceutical & biotechnology companies
-
Academic & research institutes
-
Contract research organizations (CROs)
Pharmaceutical and biotech firms account for a major market share due to expanding R&D pipelines and increasing reliance on predictive preclinical platforms.
Why Does North America Dominate the Global Market?
North America holds a dominant position due to:
-
Advanced research infrastructure
-
High R&D expenditure
-
Strong pharmaceutical and biotechnology presence
-
Robust regulatory frameworks
How Is Asia-Pacific Emerging as a High-Growth Region?
The Asia-Pacific region is projected to experience significant growth during 2025–2035, supported by expanding biotech industries in China, Japan, South Korea, and India, along with increased outsourcing and government funding initiatives.
Click Here to Download the ToC
What Emerging Trends Are Shaping the Future of Transgenic Animal Models?
1. Why Are Humanized Animal Models Gaining Importance?
Humanized mouse models, engineered with human genes or immune systems, are becoming essential in immuno-oncology and infectious disease research.
2. How Are Ethical Regulations Influencing Model Development?
Regulatory emphasis on the 3Rs principle (Replacement, Reduction, and Refinement) is driving innovation in model efficiency, minimizing animal use while maximizing data output.
3. How Is AI Integration Enhancing Preclinical Research?
The integration of artificial intelligence and digital biology with transgenic research is improving predictive modeling, data interpretation, and study optimization.
Get More Insight for Healthcare Market
The global transgenic animal model market is projected to grow to $6,799.3 million by 2035 at a CAGR of 9.29%, reflecting the increasing importance of advanced preclinical research tools.
As therapeutic pipelines become more complex and personalized medicine advances, transgenic models will remain essential for accelerating innovation, improving translational success rates, and reducing clinical trial failure risks.
About BIS Research
BIS Research, recognized as a top market research company, specializes in market research reports and advisory services focused on deep technology and emerging trends that are poised to disrupt key industrial markets. Annually, we publish over 1000+ market intelligence reports across various deep technology verticals. We help businesses stay ahead with in-depth reports, custom research, and go-to-market strategies tailored to your goals.
Media Contact
Company Name: BIS Research
Contact Person: Bhavya Banga
Email: Send Email
Phone: +1-510-404-8135
Address:39111 PASEO PADRE PKWY STE 313, FREMONT CA 94538
Country: United States
Website: https://bisresearch.com/industry-report/transgenic-animal-model-market.html